Skip to main content
Back to All Articles

Medical

Here are dozens of reasons why facilities and clinicians choose Andersen and our terminal sterilization solutions, again and again!

Ethylene Oxide Risk vs. Reward, EndoPro Mag

Ethylene Oxide Risk vs. Reward

“EO sterilization has continued to advance since the ’60s and ’70s, and while there are still risks, updates to the delivery technology, EO’s materials compatibility, and penetration capabilities mean there are rewards to the modality that you should consider,” said Seth Hendee of Healthmark Industries, Inc. in his article Ethylene Oxide Risk vs Reward.

Continue Reading

H2O2's overblown safety claims are dangerous

H2O2’s overblown safety claims are dangerous

All chemicals capable of achieving terminal sterility are inherently dangerous requiring exposure monitoring, training and engineered redundancies designed to offer the highest level of operator protection. Claiming your sterilant is “safe” and “non-toxic” does a serious disservice to users who may, then, not treat the sterilant with the respect it deserves. Our aim in this post is not to compare H2O2 and EO (both are potentially dangerous and must be used with care). Instead, we hope to demonstrate widespread instances of operator injury in hopes of encouraging fair comparison and careful use.

Continue Reading

Bridging the COVID Gap (Year)

Bridging the COVID Gap (Year)

When COVID-19 took over our lives in 2020, many felt the immediate need to help, but weren’t quite sure how. Carl May, grandson of company founder Dr. Harold W. Andersen, didn’t hesitate. He pressed pause on plans to attend college in Fall 2020 & joined Andersen’s contract sterilization sister company, Andersen Scientific, as a sterile processing technician where he spent months sterilizing millions of COVID test swabs for manufacturers across the country.

Continue Reading

Beyond Clean Expert Series Conference

An intensely honest conversation about ethylene oxide sterilization

Is ethylene oxide (EO or EtO) more toxic than hydrogen peroxide? What are the most prevalent myths about EO in the industry today? What does the future of EO look like? Andersen’s President and CEO, A.E. (Ted) May joined Beyond Clean’s Justin Poulin for an intensely honest conversation about gas sterilization. In typical Beyond Clean fashion, Poulin asked the tough questions regarding the history surrounding EO and its role in the future of hospital sterile processing departments, specifically around duodenoscope and endoscope reprocessing.

Continue Reading

FDA investigates reports of urological endoscope infections

FDA investigates urological endoscopes

The Food and Drug Administration (FDA) announced it is investigating reports of infections associated with reprocessed urological endoscopes. The FDA received more than 450 medical device reports (MDRs) describing post-procedure patient infections or other contamination issues associated with reprocessing urological endoscopes. Andersen’s EOGas 4 presents an FDA-cleared terminal sterilization option for the urological endoscopes under investigation, as well as significantly longer and smaller diameter scopes.

Continue Reading

Beyond Clean Podcast: FDA 510(k) Clearance for the EOGas 4

Beyond Clean Podcast: FDA’s Only 510(k) Clearance for Terminal Sterilization of Duodenoscopes

Andersen’s EOGas 4 is the first, and only, sterilization system FDA 510k cleared for terminal sterilization of duodenoscopes and colonoscopes. A true game changer for healthcare facilities that sterilize these critical instruments. On a recent Beyond Clean podcast, Ted May, Andersen President and CEO, and Dr. Larry Muscarella of LFM Healthcare Solutions LLC, take you inside the science behind this one-of-a-kind sterilization technology proven to sterilize the toughest endoscopes on the market.

Continue Reading